IFNG and neoplasm: showed that BTLA binding to HVEM receptors on melanoma cells inhibits IFN-g secretion and tumor-specific T cell proliferation, demonstrating that HVEM-BTLA inhibitory interactions can play a role in anti-tumor immune evasion (25).